MFG
JAZZ icon

MidWestOne Financial Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

MidWestOne Financial Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$5.59M Sell
32,855
-6,416
-16% -$984K 0.62% 26
2025
Q3 		$5.18M Buy
39,271
+4,559
+13% +$547K 0.63% 27
2025
Q2 		$3.68M Buy
34,712
+14,195
+69% +$1.54M 0.48% 47
2025
Q1 		$2.55M Sell
20,517
-3,830
-16% -$500K 0.36% 63
2024
Q4 		$3M Buy
24,347
+2,284
+10% +$269K 0.42% 50
2024
Q3 		$2.46M Buy
22,063
+1,134
+5% +$124K 0.34% 63
2024
Q2 		$2.23M Buy
20,929
+8,083
+63% +$889K 0.4% 61
2024
Q1 		$1.55M Buy
12,846
+4,084
+47% +$500K 0.28% 101
2023
Q4 		$1.08M Buy
8,762
+205
+2% +$25.6K 0.2% 120
2023
Q3 		$1.11M Sell
8,557
-3,081
-26% -$411K 0.25% 108
2023
Q2 		$1.44M Buy
11,638
+1,944
+20% +$262K 0.31% 81
2023
Q1 		$1.42M Buy
9,694
+1,833
+23% +$271K 0.32% 73
2022
Q4 		$2.67M Buy
7,861
+202
+3% +$29.6K 0.6% 23
2022
Q3 		$1.02M Sell
7,659
-275
-3% -$41.8K 0.26% 92
2022
Q2 		$1.24M Sell
7,934
-172
-2% -$26.5K 0.31% 78
2022
Q1 		$1.26M Sell
8,106
-2,827
-26% -$410K 0.27% 88
2021
Q4 		$1.39M Buy
10,933
+3,898
+55% +$512K 0.29% 84
2021
Q3 		$916K Buy
+7,035
New +$1.06M 0.21% 114
2020
Q2 		– Sell
-5,461
Closed -$545K – 155
2020
Q1 		$545K Buy
5,461
+2,077
+61% +$269K 0.2% 114
2019
Q4 		$505K Buy
+3,384
New +$461K 0.1% 148

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

MidWestOne Financial Group's JAZZ Position: Q4 2025 in Review

MidWestOne Financial Group reduced its Jazz Pharmaceuticals (JAZZ) stake by 16% in Q4 2025, selling an estimated $984K and leaving 32,855 shares worth $5.59M. The position accounts for 0.62% of the portfolio, ranked #26.

MidWestOne Financial Group first reported a position in JAZZ in Q4 2019 and has held it in 20 quarters since. 573 funds tracked by Wall St. Rank hold JAZZ as of Q4 2025.

  • MidWestOne Financial Group held 32,855 shares of Jazz Pharmaceuticals worth $5.59M as of Q4 2025.
  • MidWestOne Financial Group sold 6,416 Jazz Pharmaceuticals shares in Q4 2025, an estimated $984K.
  • Jazz Pharmaceuticals made up 0.62% of MidWestOne Financial Group's portfolio in Q4 2025, its #26 holding.
  • MidWestOne Financial Group first reported a position in Jazz Pharmaceuticals in Q4 2019 and has held it in 20 quarters since.
  • 573 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2025.

Based on MidWestOne Financial Group's 13F filing for Q4 2025, filed 12 Feb 2026.